Search results for "quinoxaline"

showing 10 items of 91 documents

CCDC 157964: Experimental Crystal Structure Determination

2001

Related Article: P.J.Skabara, R.Berridge, K.Prescott, L.M.Goldenberg, E.Orti, R.Viruela, R.Pou-Amerigo, A.S.Batsanov, J.A.K.Howard, S.J.Coles, M.B.Hursthouse|2000|J.Mater.Chem.|10|2448|doi:10.1039/b003910l

Space GroupCrystallographyCrystal SystemCrystal StructureThieno(3'4':56)(14)dithiino(23-b)quinoxaline tetracyanoquinodimethaneCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 650800: Experimental Crystal Structure Determination

2008

Related Article: C.Yuste, A.Bentama, S.-E.Stiriba, D.Armentano, G.De Munno, F.Lloret, M.Julve|2007|Dalton Trans.||5190|doi:10.1039/b709233d

Space GroupCrystallographyCrystal SystemCrystal Structurecatena-((mu~2~-tricyanomethanido-NN)-(23-bis(2-pyridyl)quinoxaline)-(tricyanomethanido-NN)-copper(ii))Cell ParametersExperimental 3D Coordinates
researchProduct

CCDC 883546: Experimental Crystal Structure Determination

2012

Related Article: J.Vallejo, J.Cano, I.Castro, M.Julve, F.Lloret, O.Fabelo, L.Canadillas-Delgado, E.Pardo|2012|Chem.Commun.|48|7726|doi:10.1039/c2cc33674j

Space GroupCrystallographyCrystal SystemCrystal Structurehexakis(Tetramethylammonium) (mu~4~-carbonato)-bis(mu~3~-23-quinoxalinediolato)-tetrakis(mu~2~-23-quinoxalinediolato)-tetraaqua-di-potassium-di-dysprosium heptahydrateCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 880437: Experimental Crystal Structure Determination

2013

Related Article: P.Albores, C.Plenk, E.Rentschler|2012|Inorg.Chem.|51|8373|doi:10.1021/ic300911j

Space GroupCrystallographybis(mu~3~-oxo)-decakis(mu~2~-pivalato)-(mu~2~-23-di(pyridin-2-yl)quinoxaline)-bis(pivalato)-diaqua-tetra-iron-di-nickel acetonitrile solvateCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

Spin crossover in six-coordinate [Fe(L)2(NCX)2] compounds with L = DPQ = 2,3-bis-(2′-pyridyl)-quinoxaline, ABPT = 4-amino-3,5-bis(pyridin-2-yl)-1,2,4…

1998

[EN] The iron(II) compounds of formulae [Fe(DPQ)2(NCS)2]·CO(CH)3)2(DPQ = 2,3-bis-(2¿-pyridyl)-quinoxaline) (1) and [Fe(ABPT)2-(NCX)2] (ABPT = 4-amino-3,5-bis(pyridin-2-yl)-1,2,4-triazole) X = S (2) and Se (3) were synthesized and the crystal structure of 1 determined by X-ray diffraction methods. It crystallizes in the monoclinic system . The structure is made up of discrete [Fe(DPQ)2(NCS)2] units. Each metal atom is in a distorted FeN6 octahedral environment, the Fe¿N bonds ranging from 2.013(8) Å to 2.425(8) Å. Variable-temperature magnetic susceptibility data in the temperature range 290¿4.2 K revealed that 1 is high spin, in contrast to 2 and 3 which show a moderately cooperative high s…

Spin transition124-TriazoleSix-coordinate complexesCrystal structureIron complexesSpin crossoverMagnetic susceptibilityInorganic Chemistrychemistry.chemical_compoundCrystallographyQuinoxalinechemistrySpin crossoverFISICA APLICADACrystal structuresMagnetic propertiesMaterials ChemistryPhysical and Theoretical ChemistrySingle crystalMonoclinic crystal systemInorganica Chimica Acta
researchProduct

Water-soluble isoindolo[2,1-a]quinoxalin-6-imines: In vitro antiproliferative activity and molecular mechanism(s) of action

2015

Abstract Water-soluble isoindoloquinoxalin (IIQ) imines and the corresponding acetates were conveniently prepared from the key intermediates 2-(2′-aminophenyl)-2H-isoindole-1-carbonitriles obtained by a Strecker reaction between substituted 1,2-dicarbaldehydes and 1,2-phenylenediamines. Both series were screened by the National Cancer Institute (Bethesda, MD) and showed potent antiproliferative activity against a panel of 60 human tumor cell lines. Several of the novel compounds showed GI50 values at a nanomolar level on the majority of the tested cell lines. Among IIQ derivatives, methoxy substituents at positions 3 and 8 or/and 9 were especially effective in impairing cell cycle progressi…

StereochemistryStrecker amino acid synthesisAntineoplastic AgentsApoptosisIsoindolo[21-a]quinoxalin-6-imineTopoisomerase I inhibitorsTopoisomerase-I InhibitorMicrotubulesTubulinCell Line TumorQuinoxalinesDrug DiscoveryHumansCytotoxic T cellCell ProliferationPharmacologyTopoisomerase I inhibitorChemistryAntitubulin agents; G-quadruplex interaction; Isoindolo[2; 1-a]quinoxalin-6-imines; Topoisomerase I inhibitors; Drug Discovery3003 Pharmaceutical Science; Organic Chemistry; PharmacologyAntitubulin agentsDrug Discovery3003 Pharmaceutical ScienceCell CycleOrganic ChemistryWaterGeneral MedicineSettore CHIM/08 - Chimica FarmaceuticaIn vitroTelomereAntitubulin agentAntitubulin agents; G-quadruplex interaction; Isoindolo[21-a]quinoxalin-6-imines; Topoisomerase I inhibitors; Drug Discovery3003 Pharmaceutical Science; Organic Chemistry; Pharmacology1-a]quinoxalin-6-iminesDNA Topoisomerases Type ISolubilityBiochemistryCell cultureApoptosisIsoindolo[2Cancer cellIminesG-quadruplex interactionDrug Screening Assays Antitumor
researchProduct

Assessing the reactivity of sodium alkyl-magnesiates towards quinoxaline : single electron transfer (SET) vs. nucleophilic alkylation processes

2015

By exploring the reactivity of sodium butyl-magnesiate (1) supported by the bulky chelating silyl(bisamido) ligand {Ph2Si(NAr*)2}(2-) (Ar* = 2,6-iPr2-C6H3) towards Quinoxaline (Qx), the ability of this bimetallic system to effectively promote SET processes has been disclosed. Thus 1 executes the single-electron reduction of Qx affording complex (2) whose structure in the solid state contains two quinaxolyl radical anions Qx˙ stabilised within a dimeric magnesiate framework. Combining multinuclear NMR and EPR measurements with DFT calculations, new insights into the constitution of 2 in solution and its magnetic behaviour have been gained. Further evidence on the SET reactivity of 1 was foun…

Steric effects010405 organic chemistryStereochemistryAlkylation010402 general chemistry01 natural sciencesMedicinal chemistry0104 chemical sciencesInorganic Chemistrychemistry.chemical_compoundQuinoxalineNucleophilechemistryAmideAlkoxideReactivity (chemistry)QDAmination
researchProduct

SYNTHESIS OF TETRACYCLIC SYSTEMS WITH POTENT ANTITUMOR ACTIVITY

2011

TETRACYCLIC SYSTEMS QUINOXALINES ANTITUMOR ACTIVITYQUINOXALINESTETRACYCLIC SYSTEMS; QUINOXALINES; ANTITUMOR ACTIVITYTETRACYCLIC SYSTEMSSettore CHIM/08 - Chimica FarmaceuticaANTITUMOR ACTIVITY
researchProduct

Inhibitory influence of chromogranin A N-terminal fragment (vasostatin-1) on the spontaneous contractions of rat proximal colon

2005

Very little is known about the role played by CGA and its fragments in the gastrointestinal physiology. We have studied the role of CGA N-terminal fragments in the regulation of intestinal smooth muscle contractility by measuring the influence of recombinant CGA 1-78 (VS-1) and synthetic CGA 7-57 peptides on the spontaneous mechanical activity of rat proximal colon in vitro. The mechanical activity was recorded as changes in the intraluminal pressure. VS-1 (0.1-30 nM) and CGA 7-57 (10-300 nM) produced concentration-dependent inhibitory effects, characterized by a progressive decrease in the mean amplitude of circular muscle spontaneous contractions, without affecting the resting tone. The r…

Time FactorsPhysiologyClinical BiochemistrySettore BIO/09 - FisiologiaBiochemistrylaw.inventionchemistry.chemical_compoundEndocrinologylawEnzyme InhibitorsIntestinal smooth muscleOxadiazolesCGA-derived peptideVasostatin-1Chromogranin ASmooth muscle contractionRecombinant ProteinsNG-Nitroarginine Methyl EsterRecombinant DNATetrodotoxinMuscle Contractionendocrine systemmedicine.medical_specialtyColonTetrodotoxinBiologyInhibitory postsynaptic potentialApaminNitric oxideCellular and Molecular NeuroscienceQuinoxalinesInternal medicineChromograninsPressuremedicineAnimalsRats WistarDose-Response Relationship DrugMuscle SmoothNitric oxidePeptide FragmentsIn vitroProtein Structure TertiaryRatsGastrointestinal TractEndocrinologyApaminchemistrybiology.proteinChromogranin ACalreticulinPeptidesRegulatory Peptides
researchProduct

CCDC 880438: Experimental Crystal Structure Determination

2013

Related Article: P.Albores, C.Plenk, E.Rentschler|2012|Inorg.Chem.|51|8373|doi:10.1021/ic300911j

bis(mu~3~-oxo)-decakis(mu~2~-pivalato)-(mu~2~-23-di(pyridin-2-yl)quinoxaline)-bis(pivalato)-diaqua-tetra-iron-di-cobalt acetonitrile solvateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct